{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Neurontin was approved by the F.D.A. in 1994 to treat epileptic seizures, but it may also provide relief for women suffering hot flashes.", "headline": {"main": "A Chance Find, and Voil\u00e0! Goodbye, Hot Flashes. Hello, Sleep.", "kicker": "Personal Health", "print_headline": "A Chance Find, and Voil\u00e0! Goodbye, Hot Flashes. Hello, Sleep.", "content_kicker": "Personal Health"}, "abstract": null, "print_page": "6", "word_count": "1090", "_id": "54b352c579881019b02c2065", "snippet": "Neurontin was approved by the F.D.A. in 1994 to treat epileptic seizures, but it may also provide relief for women suffering hot flashes.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/03/28/health/28brody.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2006/03/27/science/28brod.75.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2006/03/27/science/28brod.75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Menopause", "is_major": "N", "rank": "3", "name": "subject"}], "byline": {"person": [{"firstname": "Jane", "middlename": "E.", "lastname": "BRODY", "rank": 1, "role": "reported", "organization": ""}], "original": "By JANE E. BRODY"}, "document_type": "article", "pub_date": "2006-03-28T00:00:00Z", "section_name": "Health"}, {"type_of_material": "Summary", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "INTERNATIONAL A3-9 Shiite Leaders Halt Talks After Raid Backed by U.S. Furious Shiite Iraqi political leaders suspended difficult talks over the formation of a new government. The source of the latest trouble was an American-backed military raid on a Shiite religious compound that killed at least 16 people. A1 France Gets Ready for Protest With Prime Minister Dominique de Villepin determined to put a new labor law into effect, France is bracing for what is being called ''black Tuesday'' -- strikes and demonstrations throughout France that could bring up to two million people out on the streets and paralyze much of the country. A1 Christian Convert Released The Justice Ministry of Afghanistan has released a jailed Afghan man who faced the death penalty for converting to Christianity, a spokesman said. Abdul Rahman has been in custody for weeks but has not been formally charged. A3 Uncertainty After Ukraine Vote In an election with no clear victor that was declared by international observers to be the country's freest since its independence from the Soviet Union, the Ukraine was in gridlock as the leading political parties jockeyed for advantage to appoint a newly empowered prime minister and government. A7 Low Turnout Predicted in Israel Israelis vote today in their fourth national election in seven years, and it is widely billed as one of the most important ballots in Israel's history. Despite the high stakes Israeli pollsters are predicting voter turnout which would be the lowest ever, more than 10 percentage points below the norm. A6 No Move to Arrest Liberian The Liberian president, Ellen Johnson Sirleaf, has asked Nigeria to extradite Charles G. Taylor to Sierra Leone to face trial for war crimes. Nigeria has said that Liberia is free to come and arrest Mr. Taylor; it has made no public move to detain him. A9 NATIONAL A10-15 Measure on Immigration Advances in the Senate With Republicans deeply divided, the Senate Judiciary Committee voted to legalize the nation's 11 million undocumented immigrants and to grant them citizenship provided that they hold jobs, pass criminal background checks, learn English and pay fines and back taxes. A1 Terrorist Defends Self in Court Zacarias Moussaoui, who is facing the death penalty for the Sept. 11, 2001, terrorist attacks, took the witness stand in his own defense, only to bolster the government's case by unhesitatingly acknowledging the charges in the indictment against him and adding a few new, self-incriminating statements. A1 Gunman Uttered One Phrase The 28-year-old man who killed six young people at a Seattle house party over the weekend before killing himself had more than 300 rounds of ammunition and said only, ''There's plenty for everyone,'' as he carried out the attack, the police said. A10 Border Checkpoint Fails Test Undercover Congressional investigators successfully smuggled into the United States enough radioactive material to make two dirty bombs even after it set off alarms on radiation detectors installed at border checkpoints, a new report says. A14 First the Web, Now Washington As lawmakers and regulators begin eyeing its ventures in China and other countries and as its Web surfers worry about the privacy of their on-line searches, Google has begun ramping up its lobbying and legislative operations after largely ignoring Washington for years. A13 Iraqi Intelligence Data for All American intelligence agencies concluded long ago that Saddam Hussein had no unconventional weapons and few ties to Al Qaeda before the 2003 invasion, but an experiment in public access is giving anyone with a computer a chance to examine intelligence documents. A1 NEW YORK/REGION B1-6 Newark's Longtime Mayor Won't Seek Re-election Mayor Sharpe James, who 11 days ago entered the race for a sixth term as mayor of New Jersey's largest city, dropped out, signaling the end of a 20-year period in which the city's downtown underwent a revival. A1 Deadlock on Medicaid Fraud Eight months after promising action against Medicaid fraud, New York state lawmakers have deadlocked on two pivotal issues. B1 Mayor Tackles S.I. Traffic Mayor Bloomberg, seeking to address a single problem that Staten Islanders have persistently complained about, traffic, presented a package of transportation improvements that seeks to make Staten Island's car-based culture a bit more dependent on mass transit. B1 Van Driver May be Charged The driver of the minivan that crashed in the Andes last week, killing 12 tourists from New Jersey and Connecticut and injuring two others, is likely to be charged with involuntary manslaughter later this week, according to Chilean prosecutors. B5 SCIENCE TIMES F1-8 Debating the Danger of Bird Flu While the gradual spread of the avian flu virus from Asia into Europe and Africa has been cause for serious concern among many experts, others argue that a human pandemic is by no means inevitable. F1 Health & Fitness F5 OBITUARIES B7 Lyn Nofziger The cigar-chomping former newspaperman who served as spokesman and strategist for Ronald Reagan in Sacramento and Washington, he was 81. B7 BUSINESS DAY C1-18 Plea Deal in KPMG Case David Rivkin, one of 17 former KPMG employees indicted over sales of questionable tax shelters, pleaded guilty to charges of conspiracy and tax evasion and has agreed to cooperate with the government. C1 G.M.'s Self-Made Obstacle General Motors' jobs bank, which pays idled workers full salary and benefits, provides such a good deal that it might be an obstacle as the company tries to persuade thousands of workers to take buyouts. C1 Bell Labs and a Lucent Deal Lucent's Bell Labs, which has a long history of working for the military, is expected to become a focal point when the company's merger with Alcatel is presented to regulators in Washington for approval. C1 Alberta Becomes Oil Mecca Some of the biggest international oil companies plan to sink 100 billion Canadian dollars into the development of oil sands in Western Canada, transforming Alberta into the epicenter of a new energy-based Canadian economy. C1 Business Digest C2 EDITORIAL A16-17 Editorials: Big oil's big windfall; eBay at the bar; free trade and AIDS drugs; Verlyn Klinkenborg on Adwaitya. Columns: John Tierney, Nicholas D. Kristof. Crossword E2 TV Listings E8 Weather D8", "headline": {"main": "News Summary"}, "abstract": null, "print_page": "2", "word_count": 1014, "_id": "4fd2693d8eb7c8105d82036d", "snippet": "INTERNATIONAL   A3-9    Shiite Leaders Halt Talks After Raid Backed by U.S.  Furious Shiite Iraqi political leaders suspended difficult talks over the formation of a new government. The source of the latest trouble was an American-backed military...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9A07E7D61430F93BA15750C0A9609C8B63", "multimedia": [], "subsection_name": null, "keywords": [], "byline": null, "document_type": "article", "pub_date": "2006-03-28T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "A widely used drug that has been mired in controversy for most of its decade-long life may now bring relief to postmenopausal women whose lives have been disrupted by unrelenting hot flashes. The relief may be especially welcome to women who have had breast cancer and cannot take estrogen. The drug, best known by its trade name, Neurontin, but now prescribed generically as gabapentin, was approved by the Food and Drug Administration in 1994 to treat epileptic seizures. In 2002, it was approved to treat postherpetic neuralgia, horrific pain that sometimes follows shingles.", "headline": {"main": "A Chance Find, and Voil\u00e0! Goodbye, Hot Flashes. Hello, Sleep.", "kicker": "PERSONAL HEALTH"}, "abstract": "Jane E Brody Personal Health column describes off-label use of pain killer Neurontin to help women experiencing hot flashes and night sweats; drawing (M)", "print_page": "6", "word_count": 1204, "_id": "4fd26ab18eb7c8105d82235c", "snippet": "A widely used drug that has been mired in controversy for most of its decade-long life may now bring relief to postmenopausal women whose lives have been disrupted by unrelenting hot flashes. The relief may be especially welcome to women who have had...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9D07E5D91430F93BA15750C0A9609C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "PERSONAL HEALTH (TIMES COLUMN)"}, {"name": "persons", "value": "BRODY, JANE E"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PAIN"}, {"name": "subject", "value": "NEURONTIN (DRUG)"}, {"name": "subject", "value": "MENOPAUSE"}], "byline": null, "document_type": "article", "pub_date": "2006-03-28T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Money and Business/Financial Desk", "lead_paragraph": "AS they tell the story, it seemed like just an office turf war. Three summers ago, Daryl Smith, a sales representative for Gradient Analytics, a small independent research firm here, says he participated in a conference call with his biggest prospective client, a unit of SAC Capital Advisors, a powerful hedge fund on Wall Street.", "headline": {"main": "True or False: A Hedge Fund Plotted to Hurt A Drug Maker?"}, "abstract": "Article on racketeering lawsuit filed by pharmaceutical company Biovail against Wall Street hedge fund SAC Capital Advisors, Gradient Analytics, research firm in Scottsdale, Ariz, and Banc of America Securities analyst and others; suit alleges that some of nation's biggest hedge funds colluded with independent research firms and analysts at big banks to produce purposely misleading research aimed at driving down company stock prices; photos (M)", "print_page": "1", "word_count": 2874, "_id": "4fd2ab818eb7c8105d8986e0", "snippet": "A lawsuit takes aim at short-selling and negative research.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/03/26/business/yourmoney/26gradient.html", "multimedia": [{"url": "images/2006/03/26/business/grad.75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2006/03/26/business/grad.75.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "organizations", "value": "SAC CAPITAL MANAGEMENT"}, {"name": "organizations", "value": "BIOVAIL CORP"}, {"name": "organizations", "value": "GRADIENT ANALYTICS"}, {"name": "organizations", "value": "BANC OF AMERICA SECURITIES"}, {"name": "subject", "value": "SECURITIES AND COMMODITIES VIOLATIONS"}, {"name": "subject", "value": "RACKETEERING AND RACKETEERS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "STOCKS AND BONDS"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "HEDGE FUNDS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Jenny", "rank": 1, "lastname": "ANDERSON"}], "original": "By JENNY ANDERSON"}, "document_type": "article", "pub_date": "2006-03-26T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 4, "offset": 0, "time": 47}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}